Ettore Novellino
Ettore Novellino
Verified email at
Cited by
Cited by
Topological characterization of nucleic acid G‐quadruplexes by UV absorption and circular dichroism
AI Karsisiotis, NM Hessari, E Novellino, GP Spada, A Randazzo, ...
Angewandte Chemie 123 (45), 10833-10836, 2011
Geometrically and conformationally restrained cinnamoyl compounds as inhibitors of HIV-1 integrase: synthesis, biological evaluation, and molecular modeling
M Artico, R Di Santo, R Costi, E Novellino, G Greco, S Massa, ...
Journal of medicinal chemistry 41 (21), 3948-3960, 1998
High-resolution structures of two complexes between thrombin and thrombin-binding aptamer shed light on the role of cations in the aptamer inhibitory activity
I Russo Krauss, A Merlino, A Randazzo, E Novellino, L Mazzarella, F Sica
Nucleic acids research 40 (16), 8119-8128, 2012
New α-(N)-heterocyclichydrazones: evaluation of anticancer, anti-HIV and antimicrobial activity
L Savini, L Chiasserini, V Travagli, C Pellerano, E Novellino, S Cosentino, ...
European journal of medicinal chemistry 39 (2), 113-122, 2004
Nutraceutical potential and antioxidant benefits of red pitaya (Hylocereus polyrhizus) extracts
GC Tenore, E Novellino, A Basile
Journal of functional foods 4 (1), 129-136, 2012
Molecular basis of cyclooxygenase enzymes (COXs) selective inhibition
V Limongelli, M Bonomi, L Marinelli, FL Gervasio, A Cavalli, E Novellino, ...
Proceedings of the National Academy of Sciences 107 (12), 5411-5416, 2010
To each his own: isonitriles for all flavors. Functionalized isocyanides as valuable tools in organic synthesis
M Giustiniano, A Basso, V Mercalli, A Massarotti, E Novellino, GC Tron, ...
Chemical Society Reviews 46 (5), 1295-1357, 2017
Arylthioindole inhibitors of tubulin polymerization. 3. Biological evaluation, structure− activity relationships and molecular modeling studies
G La Regina, MC Edler, A Brancale, S Kandil, A Coluccia, F Piscitelli, ...
Journal of medicinal chemistry 50 (12), 2865-2874, 2007
Non-nucleoside HIV-1 reverse transcriptase (RT) inhibitors: past, present, and future perspectives
G Campiani, A Ramunno, G Maga, V Nacci, C Fattorusso, B Catalanotti, ...
Current pharmaceutical design 8 (8), 615-657, 2002
Toward a quantitative comparative toxicology of organic compounds
C Hansch, D Kim, AJ Leo, E Novellino, C Silipo, A Vittoria, JA Bond, ...
CRC critical reviews in toxicology 19 (3), 185-226, 1989
Specific targeting of acetylcholinesterase and butyrylcholinesterase recognition sites. Rational design of novel, selective, and highly potent cholinesterase inhibitors
L Savini, A Gaeta, C Fattorusso, B Catalanotti, G Campiani, L Chiasserini, ...
Journal of medicinal chemistry 46 (1), 1-4, 2003
5-Alkyl-2-(alkylthio)-6-(2,6-dihalophenylmethyl)-3,4-dihydropyrimidin-4(3H)-ones:  Novel Potent and Selective Dihydro-alkoxy-benzyl-oxopyrimidine Derivatives
A Mai, M Artico, G Sbardella, S Massa, E Novellino, G Greco, AG Loi, ...
Journal of medicinal chemistry 42 (4), 619-627, 1999
Nutraceuticals: A paradigm of proactive medicine
A Santini, GC Tenore, E Novellino
European Journal of Pharmaceutical Sciences 96, 53-61, 2017
Docking Studies on αvβ3 Integrin Ligands:  Pharmacophore Refinement and Implications for Drug Design
L Marinelli, A Lavecchia, KE Gottschalk, E Novellino, H Kessler
Journal of medicinal chemistry 46 (21), 4393-4404, 2003
Design, molecular modeling, synthesis, and anti-HIV-1 activity of new indolyl aryl sulfones. Novel derivatives of the indole-2-carboxamide
R Ragno, A Coluccia, G La Regina, G De Martino, F Piscitelli, ...
Journal of medicinal chemistry 49 (11), 3172-3184, 2006
An N-glucosylated peptide detecting disease-specific autoantibodies, biomarkers of multiple sclerosis
F Lolli, B Mulinacci, A Carotenuto, B Bonetti, G Sabatino, B Mazzanti, ...
Proceedings of the National Academy of Sciences 102 (29), 10273-10278, 2005
Structure-based design, synthesis, and biological evaluation of conformationally restricted novel 2-alkylthio-6-[1-(2, 6-difluorophenyl) alkyl]-3, 4-dihydro-5-alkylpyrimidin-4 …
A Mai, G Sbardella, M Artico, R Ragno, S Massa, E Novellino, G Greco, ...
Journal of medicinal chemistry 44 (16), 2544-2554, 2001
Nutraceuticals: Opening the debate for a regulatory framework
A Santini, SM Cammarata, G Capone, A Ianaro, GC Tenore, L Pani, ...
British journal of clinical pharmacology 84 (4), 659-672, 2018
Urantide: an ultrapotent urotensin II antagonist peptide in the rat aorta
R Patacchini, P Santicioli, S Giuliani, P Grieco, E Novellino, P Rovero, ...
British journal of pharmacology 140 (7), 1155-1158, 2003
Pyrido[1,2-a]pyrimidin-4-one Derivatives as a Novel Class of Selective Aldose Reductase Inhibitors Exhibiting Antioxidant Activity
C La Motta, S Sartini, L Mugnaini, F Simorini, S Taliani, S Salerno, ...
Journal of Medicinal Chemistry 50 (20), 4917-4927, 2007
The system can't perform the operation now. Try again later.
Articles 1–20